Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
Latest reported ACRS revenue for 2026-06-30 was $3.6M. Net income was -$41.3M. Revenue was up 81.6% from 2026-03-31 to 2026-06-30. ACRS currently screens at market cap $615.9M.
Use this ACRS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ACRS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ACRS SEC filings page. Lician reads the product cache first so this HTML stays unique to Aclaris Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ACRS income, balance, and cash tables.